Curative Biotechnology Stock Analysis

Curative Stock Analysis Notes

The company had not issued any dividends in recent years. Curative Biotechnology had 1:400 split on the 2nd of December 2022. Curative Biotechnology, Inc. operates as a development-stage biomedical company. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida. Curative Biotechnology operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people. For more info on Curative Biotechnology please contact JD Esq at 561 907 8990 or go to https://curativebiotech.com.

Curative Biotechnology Investment Alerts

Curative Biotechnology Thematic Classifications

Curative Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.4 M.

Curative Profitablity

Management Efficiency

Curative Biotechnology has return on total asset (ROA) of (0.6402) % which means that it has lost $0.6402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.9828) %, meaning that it created substantial loss on money invested by shareholders. Curative Biotechnology's management efficiency ratios could be used to measure how well Curative Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Curative Biotechnology's Return On Capital Employed is comparatively stable compared to the past year. Return On Equity is likely to gain to 0.69 in 2026, despite the fact that Return On Tangible Assets are likely to grow to (4.78). Total Current Liabilities is likely to gain to about 8.5 M in 2026. Liabilities And Stockholders Equity is likely to gain to about 2.6 M in 2026

Technical Drivers

As of the 31st of January, Curative Biotechnology shows the Downside Deviation of 13.35, risk adjusted performance of 0.0548, and Mean Deviation of 9.33. Curative Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Curative Biotechnology Price Movement Analysis

Curative Biotechnology Outstanding Bonds

Curative Biotechnology Predictive Daily Indicators

Curative Biotechnology Forecast Models

Curative Biotechnology's time-series forecasting models are one of many Curative Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Curative Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Curative Biotechnology Bond Ratings

Curative Biotechnology financial ratings play a critical role in determining how much Curative Biotechnology have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Curative Biotechnology's borrowing costs.

Curative Biotechnology Debt to Cash Allocation

Curative Biotechnology currently holds 1.37 M in liabilities with Debt to Equity (D/E) ratio of 6.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Curative Biotechnology has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Curative Biotechnology's use of debt, we should always consider it together with its cash and equity.

Curative Biotechnology Common Stock Shares Outstanding Over Time

Curative Biotechnology Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Curative Biotechnology uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Curative Biotechnology Debt Ratio

69.0

It appears slightly above 31% of Curative Biotechnology's assets are financed be debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Curative Biotechnology's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Curative Biotechnology, which in turn will lower the firm's financial flexibility.

Curative Biotechnology Corporate Bonds Issued

Curative Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Curative Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Curative shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Curative Biotechnology. By using and applying Curative Stock analysis, traders can create a robust methodology for identifying Curative entry and exit points for their positions.

When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.